Literature DB >> 31433548

Tumor mutational burden.

Lauren L Ritterhouse.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31433548     DOI： 10.1002/cncy.22174

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN： 1934-662X            Impact factor:   5.284


× No keyword cloud information.
  19 in total

1.  Identification and Development of Subtypes with Poor Prognosis in Gastric Cancer Based on Both Hypoxia and Immune Cell Infiltration.

Authors:  Yao Wang; Jingjing Sun; Yang Yang; Sonia Zebaze Dongmo; Yeben Qian; Zhen Wang
Journal:  Int J Gen Med       Date:  2021-12-06

2.  The Prognostic Assessment of CDC20 in Patients with Renal Clear Cell Carcinoma and Its Relationship with Body Immunity.

Authors:  Jiaqi Shi; Yinhao Chen; Xiameng Gu; Xuerong Wang; Jing Liu; Xiaolan Chen
Journal:  Contrast Media Mol Imaging       Date:  2022-06-08       Impact factor: 3.009

Review 3.  Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.

Authors:  Jong Chul Park; Hari N Krishnakumar; Srinivas Vinod Saladi
Journal:  Curr Oncol       Date:  2022-06-08       Impact factor: 3.109

4.  COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.

Authors:  Shiwei Liu; Yang Yu; Yi Wang; Bingye Zhu; Bangmin Han
Journal:  Eur J Med Res       Date:  2022-07-16       Impact factor: 4.981

5.  Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.

Authors:  Lei Li; Xi Chen; Lu Hao; Qiuyan Chen; Haosheng Liu; Qing Zhou
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

6.  Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker.

Authors:  Yingqi Qiu; Hao Wang; Peiyun Liao; Binyan Xu; Rong Hu; Yulu Yang; Yuhua Li
Journal:  BMC Genom Data       Date:  2022-01-16

7.  The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma.

Authors:  Xinming Chen; Zheng Zhu; Xiaoling Li; Xinyue Yao; Lianxiang Luo
Journal:  Front Oncol       Date:  2021-11-01       Impact factor: 6.244

8.  Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.

Authors:  Zongcai Yan; Meiling He; Lifeng He; Liuxia Wei; Yumei Zhang
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

9.  An miRNA signature associated with tumor mutation burden in endometrial cancer.

Authors:  Hongyu Zhou; Lihua Chen; Mei Qin; Yajie Lei; Tianjiao Li; Haoran Li; Xi Cheng
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

10.  MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer.

Authors:  Nan Lu; Jinhui Liu; Chengjian Ji; Yichun Wang; Zhipeng Wu; Shuning Yuan; Yan Xing; Feiyang Diao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.